[1]
F. L. Casado, K. R. Salci, Z. Shapovalova, B. Guezguez, T. J. Collins, and M. Bhatia, “Expansion of Primary Human AML by Aryl Hydrocarbon Receptor Antagonism Minimally Affects Leukemic Transcriptional Profiles but Alters Cellular Metabolism”, J. Hematol. Res., vol. 2, no. 1, pp. 9–16, Mar. 2015.